Adverse events590

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 590

Type	Event	Organ system	Group	Affected	At risk
other	Gastritis	Gastrointestinal disorders	Run-in Period: Aliskiren + Hydrochlorothiazide (HCTZ)	0	1,335
other	Gastritis	Gastrointestinal disorders	Run-in Period: Aliskiren + Amlodipine	0	1,001
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Aliskiren + Hydrochlorothiazide (HCTZ)	0	244
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Aliskiren + Placebo for HCTZ	0	232
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Aliskiren + Amlodipine	0	189
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Aliskiren + Placebo for Amlodipine	2	195
other	Gastritis	Gastrointestinal disorders	Double Blind Period: HCTZ + Placebo for Aliskiren	0	251
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Placebo for Aliskiren + Placebo for HCTZ	0	253
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Amlodipine + Placebo for Aliskiren	1	196
other	Gastritis	Gastrointestinal disorders	Double Blind Period: Placebo for Aliskiren + Placebo for Amlod	1	199
other	Oedema peripheral	General disorders	Run-in Period: Aliskiren + Hydrochlorothiazide (HCTZ)	0	1,335
other	Oedema peripheral	General disorders	Run-in Period: Aliskiren + Amlodipine	7	1,001
other	Oedema peripheral	General disorders	Double Blind Period: Aliskiren + Hydrochlorothiazide (HCTZ)	0	244
other	Oedema peripheral	General disorders	Double Blind Period: Aliskiren + Placebo for HCTZ	1	232
other	Oedema peripheral	General disorders	Double Blind Period: Aliskiren + Amlodipine	4	189
other	Oedema peripheral	General disorders	Double Blind Period: Aliskiren + Placebo for Amlodipine	0	195
other	Oedema peripheral	General disorders	Double Blind Period: HCTZ + Placebo for Aliskiren	0	251
other	Oedema peripheral	General disorders	Double Blind Period: Placebo for Aliskiren + Placebo for HCTZ	2	253
other	Oedema peripheral	General disorders	Double Blind Period: Amlodipine + Placebo for Aliskiren	7	196
other	Oedema peripheral	General disorders	Double Blind Period: Placebo for Aliskiren + Placebo for Amlod	1	199

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01259297/events

API reference For AI assistants

Adverse events590

Sources 3

Read this list from software.